Oliver Lagore Vanvalin Investment Group’s AbbVie ABBV Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$514K	Buy	+2,454	New	+$456K	0.2%	91
2024 Q4	$26.1K	Buy	147 +25	+20%	+$4.6K	0.01%	329
2024 Q3	$24.1K	Sell	122 -30	-20%	-$5.6K	0.01%	325
2024 Q2	$26.1K	Sell	152 -34	-18%	-$5.63K	0.01%	307
2024 Q1	$33.9K	Sell	186 -35	-16%	-$6.03K	0.01%	278
2023 Q4	$34.2K	Sell	221 -104	-32%	-$15.2K	0.01%	247
2023 Q3	$48.4K	Buy	325 +39	+14%	+$5.72K	0.02%	243
2023 Q2	$38.5K	Buy	286 +6	+2%	+$880	0.01%	280
2023 Q1	$44.6K	Sell	280 -24	-8%	-$3.67K	0.02%	200
2022 Q4	$49.1K	Buy	304 +102	+50%	+$15.6K	0.03%	182
2022 Q3	$27K	Buy	202 +93	+85%	+$13.3K	0.02%	222
2022 Q2	$17K	Hold	109	–	–	0.01%	271
2022 Q1	$17K	Buy	+109	New	+$15.8K	0.01%	268

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Oliver Lagore Vanvalin Investment Group's ABBV Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in AbbVie (ABBV) in Q2 2025: 2,454 shares worth $514K. The stake represents 0.2% of the portfolio and ranks #91 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in ABBV as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in ABBV in Q1 2022 and has held it in 13 quarters since. 3,781 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Oliver Lagore Vanvalin Investment Group held 2,454 shares of AbbVie worth $514K as of Q2 2025.
AbbVie was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
AbbVie made up 0.2% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #91 holding.
Oliver Lagore Vanvalin Investment Group first reported a position in AbbVie in Q1 2022 and has held it in 13 quarters since.
3,781 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.